Skip to content

Clinical trials

Completed Macular Degeneration trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20101
20111
20132
20171
20191
20202
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Universitaire Ziekenhuizen KU Leuven3
Brugmann University Hospital2
GlaxoSmithKline2
Astellas Pharma Global Development, Inc.1
Bayer1
IVERIC bio, Inc.1
Janssen Research & Development, LLC1
Laurence Postelmans1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration19
Choroidal Neovascularization5
Geographic Atrophy5
Vision Disorders3
Eye Diseases2
Retinal Diseases2
Wet Macular Degeneration2
Blindness1
Retinal Degeneration1
Retinal Vein Occlusion1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.